経口糖尿病薬の英語

プロポリス、ケール又はその抽出物を含有するエンドセリン拮抗剤、高血圧症治療剤、心疾患又は脳循環器疾患治療剤、腎疾患治療剤、喘息治療剤、潰瘍治療剤、糖尿病治療剤、これらを含む経口用組成物、食品、医薬。例文帳に追加

An endothelin antagonist, a hypertension remedy, a heart disease or cerebral circulatory system disease remedy, a renal disease remedy, an asthma remedy, an ulcer remedy, a diabetes remedy, all containing propolis, kale, or an extract thereof are provided, together with a composition for oral administration, food, and medicine containing one of the above remedies. - 特許庁

従って、長期間服用しても安全で尚且つ確実な予防、治療を行うのに満足できるような糖吸収抑制剤、血糖値上昇あるいは内臓脂肪蓄積の抑制剤、糖尿病、肥満、高脂血症などの予防及び／又は治療剤、それを含有する経口用又は非経口用組成物、食品又は医薬を提供できる。例文帳に追加

Hence, a sugar absorption inhibitor, a blood glucose level elevation or offal fat accumulation inhibitor, or a preventing or treating agent for diabetes, obesity, hyperlipemia or the like which can safely, surely and sufficiently satisfactorily prevent or treat these diseases, even when administered for a long period, and an oral or parenteral composition, food or a medicine containing the agent can be provided. - 特許庁

従って、長期間服用しても安全で尚且つ確実な予防、治療を行うのに充分満足できるような糖吸収抑制剤、血糖値上昇あるいは内臓脂肪蓄積の抑制剤、糖尿病、肥満、高脂血症などの予防及び／又は治療剤、及びその剤を含有する経口用又は非経口用組成物、食品あるいは医薬を提供できる。例文帳に追加

Hence, a sugar absorption inhibitor, a blood glucose level elevation or offal fat accumulation inhibitor, or a preventing or treating agent for diabetes, obesity, hyperlipemia, or the like which can safely, surely and sufficiently satisfactorily prevent or treat these diseases, even when administered for a long period, and an oral or parenteral composition, food or a medicine containing the agent can be provided. - 特許庁

１型糖尿病治療のための経口投与用の医薬組成物の製造におけるＤＰＩＶ阻害剤の使用であって、該ＤＰＩＶ阻害剤がＤＰＩＶの高親和性阻害剤であり、しかも耐糖能障害を軽減しかつ膵臓組織再生を促進させるのに十分な量で１日１回の投与用に処方される、前記使用。例文帳に追加

This pharmaceutical composition for oral administration for the treatment of type 1 diabetes uses DPIV inhibitor in its manufacturing and the DPIV inhibitor is a high affinity inhibitor, and the use of the composition prescribing a sufficient quantity for administration of once a day for alleviating glucose intolerance and promoting the regeneration of pancreatic tissue is also disclosed. - 特許庁

安全かつ経口投与で高い効力を有するミトコンドリア病、特に慢性進行性外眼筋麻痺症候群（ＣＰＥＯ）、ＭＥＲＲＦ（赤色ぼろ線維を持つミトコンドリア異常を伴うミオクローヌスてんかん）、ＭＥＬＡＳ（ミトコンドリア筋症脳症高乳酸血症、脳卒中様症状）、ミトコンドリア遺伝子変異による糖尿病、心筋症、アルツハイマー痴呆症、聴覚障害、網膜変性疾患等の予防又は治療薬を提供すること。例文帳に追加

To obtain a prophylactic or therapeutic agent having safety and high efficacy by oral administration, against mitochondrial disease, especially chronic progressive external ophthalmoplegia syndrome(CPEO), MERRF(myoclonus epilepsy with ragged-red fiber), MELAS(mitochondrial encephalopathy, lactic acidosis and stroke) and diabetes, cardiomyopathy, Alzheimer's dementia, auditory difficulties, and retinal degenerative disease caused by mitochondrial genetic variation. - 特許庁